Sequenom controversies
Controversies tied to this brand in public sources. A listing is not a finding of fault.
Back to profile3 entries
2011
SEC cease-and-desist order
Sequenom entered into a cease-and-desist order with the Securities and Exchange Commission following the prenatal-test controversy.
2010
Shareholder litigation and SEC investigation
Sequenom paid $14 million to settle a shareholder class-action lawsuit arising from problems in the Down syndrome test’s development. Company executives were also investigated in connection with alleged insider trading before the test problems became public.
2009
SEQureDx prenatal-test controversy
An investigation found serious flaws in studies supporting the effectiveness of Sequenom’s SEQureDx prenatal screening program. The findings led to executive dismissals and resignations, regulatory scrutiny, and a major loss of confidence in the company’s oversight of prenatal testing.